ANTIBODY PREVALENCE TO HEPATITIS-C AND PARENTERAL TRANSMITTED VIRUS DISEASES IN INTRAVENOUS-DRUG-USERS

被引：0
|
作者：
NEUWALD, C [1 ]
PONT, J [1 ]
TOMASITS, J [1 ]
BAUER, K [1 ]
机构：
[1] STADT WIEN,KAISER FRANZ JOSEF SPITALS,MED ABT 3,A-1100 VIENNA,AUSTRIA
来源：
ACTA MEDICA AUSTRIACA | 1992年 / 19卷 / 02期
关键词：
IV DRUG USERS; HEPATITIS-C; HEPATITIS-B; HIV; HTLV-I;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum samples of 151 intravenous drug users were tested for markers of hepatitis B, hepatitis C, HIV and HTLV-I infection to estimate the prevalence of blood born virus infection in this high risk group. Anti-HCV antibodies were found in 75% of sera. Seroprevalence for HIV was found 13%, for hepatitis B markers 68% and none for HTLV-I. Multiple infections have been very frequent.
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [11] MOLECULAR EPIDEMIOLOGY OF HEPATITIS-C VIRUS-INFECTION AMONGST INTRAVENOUS-DRUG-USERS IN RURAL COMMUNITIES
    MAJID, A
    HOLMES, R
    DESSELBERGER, U
    SIMMONDS, P
    MCKEE, TA
    JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (01) : 48 - 51
  • [12] SEXUAL TRANSMISSION OF HEPATITIS-C VIRUS AND HIV-1 INFECTION IN FEMALE INTRAVENOUS-DRUG-USERS
    SALVAGGIO, A
    CONTI, M
    ALBANO, A
    PIANETTI, A
    MUGGIASCA, ML
    RE, M
    SALVAGGIO, L
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1993, 9 (03) : 279 - 284
  • [13] PREVALENCE OF SEROLOGICAL MARKERS OF HEPATITIS-C, HEPATITIS-B AND HEPATITIS-D AND HISTOLOGICAL ASPECTS IN INTRAVENOUS-DRUG-USERS
    LUCIDARME, D
    FOUTREIN, P
    CREUSY, C
    FORZY, G
    FOUTREINCOMES, MC
    MUYSSEN, A
    BAILLY, D
    PARQUET, PJ
    FILOCHE, B
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1994, 18 (11): : 964 - 968
  • [14] VERTICAL TRANSMISSION OF HEPATITIS-C VIRUS IN HIV-NEGATIVE INTRAVENOUS-DRUG-USERS (IVDUS) - DOES IT OCCUR
    LATT, N
    LIN, R
    FARRELL, G
    BATEY, R
    CREWE, E
    HEPATOLOGY, 1992, 16 (02) : 560 - 560
  • [15] PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN HETEROSEXUAL PARTNERS OF SUBJECTS WITH ANTIBODY TO HEPATITIS-C VIRUS
    COUZIGOU, P
    MESNIER, F
    SCHOULER, L
    GIRARD, A
    BALDIT, C
    DUMAS, F
    RAYMOND, JM
    AMOURETTI, M
    HEPATOLOGY, 1990, 12 (04) : 962 - 962
  • [16] MOLECULAR EPIDEMIOLOGY OF HEPATITIS-C INFECTION AMONG INTRAVENOUS-DRUG-USERS IN GUANGXI PROVINCE, SOUTHERN CHINA
    MIZOKAMI, M
    GE, XM
    WANG, SS
    WANG, Y
    PAN, HD
    HUANG, GY
    WU, RR
    CAO, K
    ORITO, E
    LAU, JYN
    HEPATOLOGY, 1995, 22 (04) : 953 - 953
  • [17] CONSIDERATIONS ON MARKERS OF HEPATITIS-B, HEPATITIS-C AND HEPATITIS-HIV AS INDICATORS OF RISK BEHAVIOR IN INTRAVENOUS-DRUG-USERS
    MELE, A
    BIANCOLILLI, V
    DARGENIO, P
    SAGLIOCCA, L
    JOURNAL OF PUBLIC HEALTH MEDICINE, 1993, 15 (01): : 112 - 112
  • [18] THE PREVALENCE OF PERIPHERAL NEUROPATHY IN INTRAVENOUS-DRUG-USERS
    BERGER, AR
    AREZZO, JC
    SCHAUMBURG, H
    ANNALS OF NEUROLOGY, 1994, 36 (02) : 319 - 319
  • [19] PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN CRYPTOGENIC CHRONIC LIVER-DISEASES
    DIODATI, G
    TAGGER, A
    BONETTI, P
    REALDI, G
    ALBERTI, A
    HEPATOLOGY, 1990, 12 (02) : 406 - 406
  • [20] SEXUALLY-TRANSMITTED DISEASES IN A POPULATION OF INTRAVENOUS-DRUG-USERS - ASSOCIATION WITH SEROPOSITIVITY TO THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)
    NELSON, KE
    VLAHOV, D
    COHN, S
    ODUNMBAKU, M
    LINDSAY, A
    ANTHONY, JC
    HOOK, EW
    JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03): : 457 - 463
12345